PhionX (KOSDAQ:900100)
1,046.00
-33.00 (-3.06%)
At close: Nov 17, 2026
PhionX Revenue
PhionX had revenue of 2.73B KRW in the quarter ending June 30, 2026, with 39.70% growth. This brings the company's total for the last twelve months to 6.08B, down -48.07% year-over-year. In the year 2025, PhionX had annual revenue of 6.34B, down -66.64%. That makes PhionX the 40,298th largest company in the world by revenue and 2,499th in South Korea.
Revenue (ttm)
6.08B
Revenue Growth
-48.07%
P/S Ratio
0.91
Revenue / Employee
2.03B
Employees
3
Market Cap
5.51B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.34B | -12.67B | -66.64% |
| Dec 31, 2024 | 19.01B | -19.42B | -50.54% |
| Dec 31, 2023 | 38.43B | -27.58B | -41.78% |
| Dec 31, 2022 | 66.01B | -15.71B | -19.22% |
| Dec 31, 2021 | 81.72B | 7.57B | 10.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| From Bio Co.,Ltd | 71.64B |
| KD Corporation | 64.56B |
| KS Industry | 39.08B |
| Zinitix | 34.84B |
| Yujin Technology | 34.51B |
| BioInfra | 25.62B |
| TOBESOFT | 24.90B |
| SI Resources | 21.66B |